Determinants of natural immunity against tuberculosis in an endemic setting: Factors operating at the level of macrophage-Mycobacterium tuberculosis interaction

Clinical and Experimental Immunology

Volumn 151, Issue 3, 2008, Pages 414-422

  Gaikwad, A N ^a   Sinha, Sudhir ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Cytokines; Macrophages; Opsonizing antibodies; Subclinical infection; Tuberculosis

Indexed keywords

HYDROGEN PEROXIDE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; MEMBRANE ANTIGEN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL GROWTH; BCG VACCINATION; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; INDIAN; INNATE IMMUNITY; MACROPHAGE; MALE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; OPSONIZATION; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOOD DONORS; CELLS, CULTURED; ENDEMIC DISEASES; HUMANS; IMMUNITY, NATURAL; INDIA; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38549086284     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03585.x     Document Type: Article

References (42)

1. Dye C. Global epidemiology of tuberculosis. Lancet 2006 367 : 938 40.
2. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992 257 : 1055 64.
3. Ogawa T, Uchida H, Kusumoto Y et al. Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 1991 59 : 3021 5.
4. Olobo JO, Geletu M, Demissie A et al. Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol 2001 53 : 85 91.
5. Denis M, Gregg EO, Ghandirian E. Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. Int J Immunopharmacol 1990 12 : 721 7.
6. Gomez-Reino JJ, Carmona L, Valverde VR et al. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003 48 : 2122 7.
7. Altare F, Durandy A, Lammas D et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998 280 : 1432 5.
8. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996 335 : 1941 9.
9. Condos R, Rom WN, Schluger NW. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 1997 349 : 1513 15.
10. Bekker LG, Freeman S, Murray PJ et al. TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways. J Immunol 2001 166 : 6728 34.
11. Scanga CA, Mohan VP, Tanaka K et al. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun 2001 69 : 7711 17.
12. Armstrong JA, Hart PD. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 1975 142 : 1 16.
13. Teitelbaum R, Glatman-Freedman A, Chen B et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA 1998 95 : 15688 93.
14. Hamasur B, Haile M, Pawlowski A et al. A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab′) fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol 2004 138 : 30 8.
15. Chambers MA, Gavier-Widen D, Hewinson RG. Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge. FEMS Immunol Med Microbiol 2004 41 : 93 100.
16. Williams A, Reljic R, Naylor I et al. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 2004 111 : 328 33.
17. Reljic R, Clark SO, Williams A et al. Intranasal IFN gamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection. Clin Exp Immunol 2006 143 : 467 73.
18. Lalvani A, Nagvenkar P, Udwadia Z et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001 183 : 469 77.
19. Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 1999 133 : 15 22.
20. Martineau AR, Newton SM, Wilkinson KA et al. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 2007 117 : 1988 94.
21. Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982 125 : 8 15.
22. Mehrotra J, Mittal A, Rastogi AK et al. Antigenic definition of plasma membrane proteins of bacillus Calmette-Guerin: predominant activation of human T cells by low-molecular-mass integral proteins. Scand J Immunol 1999 50 : 411 19.
23. Markwell MA, Haas SM, Bieber LL et al. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978 87 : 206 10.
24. Ivanyi J, Sinha S, Aston R et al. Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies. Clin Exp Immunol 1983 52 : 528 36.
25. Griess P. Bemerkungen zu der abhandlung der H. H. Weselsky und Benedikt 'Ueber einige azoverbindungen' [Over the azo reactions]. Chem Ber 1879 12 : 426.
26. Pick E, Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 1981 46 : 211 26.
27. Marciniuk DD, McNab BD, Martin WT, Hoeppner VH. Detection of pulmonary tuberculosis in patients with a normal chest radiograph. Chest 1999 115 : 445 52.
28. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000 161 : 1376 95.
29. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007 44 : 69 73.
30. Narayanan PR. Influence of sex, age and nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India. Indian J Med Res 2006 123 : 119 24.
31. Hirsch CS, Ellner JJ, Russell DG et al. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 1994 152 : 743 53.
32. Trivedi V, Zhang SC, Castoreno AB et al. Immunoglobulin G signaling activates lysosome/phagosome docking. Proc Natl Acad Sci USA 2006 103 : 18226 31.
33. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001 345 : 1098 104.
34. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995 13 : 251 76.
35. Jouanguy E, Doffinger R, Dupuis S et al. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol 1999 11 : 346 51.
36. Guirado E, Amat I, Gil O et al. Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice. Microbes Infect 2006 8 : 1252 9.
37. Gu S, Chen J, Dobos KM et al. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol Cell Proteomics 2003 2 : 1284 96.
38. Sinha S, Kosalai K, Arora S et al. Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology 2005 151 : 2411 19.
39. Sanchez-Rodriguez C, Estrada-Chavez C, Garcia-Vigil J et al. An IgG antibody response to the antigen 85 complex is associated with good outcome in Mexican Totonaca Indians with pulmonary tuberculosis. Int J Tuberc Lung Dis 2002 6 : 706 12.
40. Hmama Z, Sendide K, Talal A et al. Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1-alpha, 2,5-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J Cell Sci 2004 117 : 2131 40.
41. Lau YL, Chan GC, Ha SY et al. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin Infect Dis 1998 26 : 226 7.
42. Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996 183 : 2293 302.